Clinical Trials

Pancreatic Neoplasms

NCT02024009 2024-07-25

SCALOP-2

159 enrolled

Phase 2 Active not recruiting

Pancreatic Neoplasms

NCT03351296 2024-05-08

BETTER2

140 enrolled

Pancreatic Neoplasms

NCT04371224 2024-04-19

NaliCap

200 enrolled

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pancreatic Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

2 enrolled

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT01525082 2024-02-06

Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors

EndocrineGastrointestinal

20 enrolled 15 charts

Glucagonoma, Insulinoma, Pancreatic Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

NCT03376659 2024-02-05

Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

Phase 1/2 Terminated

8 enrolled 14 charts

Phase EARLY_PHASE1 Withdrawn

Pancreatic Neoplasms, Colorectal Neoplasms

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT06217042 2024-01-22

HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer

Phase 3 Not yet recruiting

524 enrolled

Pancreatic Neoplasms

NCT06202014 2024-01-19

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

43 enrolled

Pancreatic Neoplasms

NCT01726582 2023-08-14

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

229 enrolled 14 charts

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT01845337 2023-05-12

TOFFEE

59 enrolled

Bile Duct Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms

NCT05566743 2022-10-04

A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas

40 enrolled

Pancreatic Neoplasms

NCT01497392 2022-07-22

Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers

26 enrolled

Pancreatic Neoplasms

NCT02451553 2022-06-07

Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer

41 enrolled

Bile Duct Neoplasms, Pancreatic Neoplasms

NCT01918644 2022-06-01

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

21 enrolled

Pancreatic Neoplasms

NCT01360593 2022-03-08

Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma

35 enrolled 18 charts

Pancreatic Neoplasms

NCT01683422 2021-08-10

Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer

Phase NA Terminated

9 enrolled 8 charts

Pancreatic Neoplasms

NCT02368860 2021-06-01

OXIRI

33 enrolled

Pancreatic Neoplasms

NCT01591733 2021-05-28

FOLFIRINOX + RT for Pancreatic Cancer

48 enrolled 16 charts

Pancreatic Neoplasms

NCT01459614 2021-05-19

Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer

44 enrolled 12 charts

Pancreatic Neoplasms

NCT03959150 2021-04-30

Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer

Phase 2/3 Unknown

231 enrolled

Pancreatic Neoplasms

NCT01077986 2021-04-21

Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer

35 enrolled

Pancreatic Neoplasms

NCT01494155 2021-02-02

Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer

50 enrolled

Pancreatic Neoplasms

NCT00634751 2019-11-26

CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma

48 enrolled 13 charts

Bile Duct Neoplasms, Pancreatic Neoplasms

NCT02352831 2019-08-28

Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Phase 1/2 Terminated

16 enrolled 15 charts

Pancreatic Neoplasms

NCT00030732 2019-05-15

Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer

Phase 3 Completed

319 enrolled

Pancreatic Neoplasms

NCT02581501 2019-04-18

Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer

Phase 1 Withdrawn

Neoplasm Metastasis, Pancreatic Neoplasms

NCT01760252 2019-03-15

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Phase 2 Terminated

17 enrolled

Pancreatic Neoplasms

NCT00438256 2019-01-23

Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer

50 enrolled 7 charts

Pancreatic Neoplasms

NCT01032057 2018-10-26

SCALOP

114 enrolled

Pancreatic Neoplasms

NCT00276744 2018-10-24

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Phase 2 Terminated

249 enrolled 4 charts

Pancreatic Neoplasms

NCT00003867 2018-09-10

Irinotecan and Capecitabine in Treating Patients With Solid Tumors